Medicalgorithmics Stock

Medicalgorithmics Revenue

The revenue of Medicalgorithmics (MDG.WA) as of Mar 19, 2026.

Revenue

0PLN

Last updated:

In 2026, Medicalgorithmics's sales reached 0 PLN, a % difference from the 0 PLN sales recorded in the previous year.

The Medicalgorithmics Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

REVENUE (M PLN)
GROSS MARGIN (%)
Date
REVENUE (M PLN)
GROSS MARGIN (%)
Jan 1, 2011
5.8 base
5,172 base
Jan 1, 2012
11 base
6,364 base
Jan 1, 2013
15.7 base
6,306 base
Jan 1, 2014
29.71 base
4,633 base
Jan 1, 2015
49.33 base
4,234 base
Jan 1, 2016
127.92 base
1,757 base
Jan 1, 2017
203.35 base
2,296 base
Jan 1, 2018
199.4 base
1,680 base
Jan 1, 2019
173.87 base
120 base
Jan 1, 2020
111.73 base
-3,018 base
Jan 1, 2021
48.35 base
7,949 base
Jan 1, 2022
62.72 base
8,030 base
Jan 1, 2023
43.1 base
8,322 base
Jan 1, 2024
24 base
8,486 base
Invalid Date
30.87 base
6,599 base
YEARREVENUE (M PLN)GROSS MARGIN (%)
2028 est 97.7320,84
2027 est 76.8726,50
2026 est 57.6635,33
2025 est 30.8765,99
2024 2484,86
2023 43.183,22
2022 62.7280,30
2021 48.3579,49
2020 111.73-30,18
2019 173.871,20
2018 199.416,80
2017 203.3522,96
2016 127.9217,57
2015 49.3342,34
2014 29.7146,33
2013 15.763,06
2012 1163,64
2011 5.851,72
Access this data via the Eulerpool API
Get Free API Key

Medicalgorithmics Revenue

Medicalgorithmics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2011
5.8 M PLN
3.1 M PLN
3 M PLN
Jan 1, 2012
11 M PLN
7.1 M PLN
7.4 M PLN
Jan 1, 2013
15.7 M PLN
10 M PLN
10.9 M PLN
Jan 1, 2014
29.71 M PLN
13.89 M PLN
14.53 M PLN
Jan 1, 2015
49.33 M PLN
21.13 M PLN
13.93 M PLN
Jan 1, 2016
127.92 M PLN
18.87 M PLN
40.11 M PLN
Jan 1, 2017
203.35 M PLN
41.82 M PLN
25.54 M PLN
Jan 1, 2018
199.4 M PLN
25.4 M PLN
14.42 M PLN
Jan 1, 2019
173.87 M PLN
55,000 PLN
4.28 M PLN
Jan 1, 2020
111.73 M PLN
-38.46 M PLN
-12.92 M PLN
Jan 1, 2021
48.35 M PLN
12.13 M PLN
-180.64 M PLN
Jan 1, 2022
62.72 M PLN
16.02 M PLN
-11.86 M PLN
Jan 1, 2023
43.1 M PLN
552,000 PLN
-578,000 PLN
Jan 1, 2024
24 M PLN
-13.86 M PLN
-16.08 M PLN
Invalid Date
30.87 M PLN
-10.22 M PLN
-10.9 M PLN

Medicalgorithmics Margins

Medicalgorithmics stock margins

The Medicalgorithmics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medicalgorithmics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medicalgorithmics.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2011
51.72 %
53.45 %
51.72 %
Jan 1, 2012
63.64 %
64.55 %
67.27 %
Jan 1, 2013
63.06 %
63.69 %
69.43 %
Jan 1, 2014
46.33 %
46.75 %
48.89 %
Jan 1, 2015
42.34 %
42.83 %
28.23 %
Jan 1, 2016
17.57 %
14.75 %
31.35 %
Jan 1, 2017
22.96 %
20.57 %
12.56 %
Jan 1, 2018
16.8 %
12.74 %
7.23 %
Jan 1, 2019
1.2 %
0.03 %
2.46 %
Jan 1, 2020
-30.18 %
-34.42 %
-11.56 %
Jan 1, 2021
79.49 %
25.09 %
-373.61 %
Jan 1, 2022
80.3 %
25.55 %
-18.91 %
Jan 1, 2023
83.22 %
1.28 %
-1.34 %
Jan 1, 2024
84.86 %
-57.76 %
-67 %
Invalid Date
84.86 %
-33.1 %
-35.33 %

Medicalgorithmics Stock analysis

What does Medicalgorithmics do? Medicalgorithmics is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Medicalgorithmics's Sales Figures

The sales figures of Medicalgorithmics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Medicalgorithmics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Medicalgorithmics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Medicalgorithmics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Medicalgorithmics stock

On Eulerpool you can find the complete historical development of The revenue Medicalgorithmics since 2006 – with annual values, charts, and detailed analysis.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Medicalgorithmics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — Medicalgorithmics